Investing in Cardiovascular Innovations—What Does The Future Hold?

Name: Investing in Cardiovascular Innovations—What Does The Future Hold?
Start: 2024-09-05 16:45:00
End: 2024-09-05 17:30:00

September 05, 2024 | 04:45 PM (EST) - 05:30 PM (EST)

Share This event

Speakers

Stephen Flaim

Senior Special Advisor & Investor-In-Residence | President | Director

National Heart Lung and Blood Institute, NIH | Flaim Partners Consulting | Haima Therapeutics

Daniel Gottlieb

Director of the MedTech Portfolio

Broadview Ventures

David Kim

Managing Director

digiTx Partners

Giovanni Leo

Partner

Lake Geneva Ventures Fund at Efficient Frontier Investing

Charity Tarn

Senior Associate | Board Member | Board Observer

Arboretum Ventures | SonarMD | Motif Neurotech, Reprieve Cardiovascular, Virtual Incision, Avation Medical, and Akadeum Life Sciences

Kathryn Zavala

Chief Operating Officer

MedTech Innovator

Moderator

David Roman

Managing Director in the Global Investment Research Division

Goldman Sachs

Investing in Cardiovascular Innovations—What Does The Future Hold?

Stage 01

September 05, 2024 | 04:45 PM (EST) - 05:30 PM (EST)

Investments in cardiology devices, including digital health and AI have been in decline over the past 2 years leading many to wonder “what are investors looking for?” In this session, we will explore the current trends of investments in Cardiology, Digital Health and AI and learn from current investors who invest at all stages along the technology life cycle.